2024

23/09/2024

Proteomics reports positive results for PromarkerEso oesophageal cancer test – Medical Device Network

29/08/2024

Blood test for kidney decline in Type 1 diabetes – Medical Forum

23/08/2024

Proteomics testing pinpoints future kidney disease risks – The Age

21/08/2024

The Silent Killer: Prevention is the next cure – Phase III Podcast

20/08/2024

How Digital Health Infrastructure and Advanced Medical Devices Will Increase the Opportunity for Personalised Care – Medhealth Insight

08/07/2024

Shares In Value Interview with ASX: PIQ Managing Director

24/06/2024

Proteomics International Inks Deal With Eurobio Scientific for French Distribution of Kidney Test – 360Dx

24/06/2024

Proteomics seals kidney disease test supply deal in France – The West Australian

17/06/2024

Proteomics engages Growth Medics to expand PromarkerD test reach in EU – Medical Device Network

17/06/2024

Proteomics boosts European presence with diabetes device – The West Australian

24/05/2024

Dr Borehams’s Crucible: Proteomics International Labs – Biotech Daily

16/05/2024

Breakthrough in fight against chemically resistant dieback – Curtin University

16/05/2024

Proteomics tech emerges as early dieback diagnosis key

25/03/2024

Proteomics International Inks Deal With Oxford for Endometriosis Samples – 360Dx

25/03/2024

Proteomics teams with Oxford university for endometriosis study – The West Australian

11/03/2024

The future of Endometriosis care – Phoenix Sound By Kel Myers

06/03/2024

Proteomics gets green light to continue diagnostic mission – The West Australian

29/02/2024

Proteomics stress test stamped with European patent – The West Australian

01/02/2024

Proteomics takes forward step with blood test diagnosis – The West Australian

14/01/2024

Screening for Oesophageal cancer, PromarkerEso – Healthy Living, 2GB

2023

20/12/2023

Chile deal opens wider American markets for Proteomics – The West Australian

19/12/2023

Promising health news, PromarkerEndo – ABC Perth Drive

18/12/2023

Endometriosis Diagnostic, PromarkerEndo – Channel 7 News Perth 4pm & 6pm

14/12/2023

Learning from UK’s kidney disease crisis – Medical Forum Magazine

22/11/2023

The Perth health-tech company batting well above its average – 6PR Perth Radio, Money News

22/11/2023

Proteomics on a game-changing path to address kidney disease – AusBiz

22/11/2023

Proteomics nails US pricing milestone for diabetes test – The West Australian

20/10/2023

Chronic kidney disease with Dr Richard Lipscombe – Channel 9 News Perth 5pm bulletin

09/10/2023

As kidney disease reaches critical levels, doctors urge responsibility – 6PR Perth Radio

29/09/2023

ASX Health Stocks: Proteomics soars 13pc after US sets price for PromarkerD – The Daily Telegraph

29/09/2023

US price locked in for Proteomics diabetes test – The West Australian

28/09/2023

Proteomics International Laboratories Ltd PromarkerD US Reimbursement Price & Aus Regulatory Decision – MarketScreener

27/09/2023

Proteomics develops new blood test for esophageal cancer – BioWorld

14/09/2023

Early diagnosis a step closer for those at risk of oesophageal cancer – BiotechDispatch

14/09/2023

Early detection for oesophageal cancer – Medical Forum

14/09/2023

Early Oesophageal Cancer Diagnosis Now Closer for At-Risk – Mirage News

10/09/2023

Proteomics International Laboratories Ltd (ASX:PIQ) New Oesophageal Cancer Test Presented At Global Conference – Menafn

08/09/2023

Proteomics International (ASX:PIQ) to present new oesophageal cancer test at global conference – The Market Herald

08/09/2023

Proteomics blood test primed for cancer fight – The West Australian

04/09/2023

Proteomics International Laboratories Ltd OxiDx Platform Technology Secures Patent in Japan – The West Australian

15/06/2023

Intervention needed to stop kidney disease overwhelming NHS, Kidney Research UK says – Evening Standard

14/06/2023

NHS facing ‘impossible’ challenge to care for kidney disease patients, Kidney Research UK warns – itv

11/06/2023

Kidney disease ‘could become public health emergency’ without more funding, charity warns – sky news

06/06/2023

New Kidney Research UK Report Shows Kidney Disease is a Public Health Emergency

21/05/2023

Heartbreaking impact of endometriosis on women laid bare – The West Australian

18/05/2023

Video Interview – Exclusive Agreement with Sonic Healthcare USA

10/05/2023

Proteomics International & Sonic Healthcare USA sign exclusive licence agreement

10/05/2023

Proteomics seals exclusive deal for kidney test in US – The West Australian

10/05/2023

Proteomics International (ASX:PIQ) inks exclusive licence agreement to bring PromarkerD to the US market – The Market Herald

10/05/2023

Proteomics’ PromarkerD test enters the lucrative US market – THE SENTIMENT

05/05/2023

New diagnostic blood test showcased at world’s premier endometriosis conference

03/05/2023

PromarkerD test scores show treatment with canagliflozin can lessen risk of diabetic kidney disease

26/04/2023

Clinical Advisory Board expanded to support PromarkerD USA and global rollout

26/04/2023

Proteomics boosts kidney test prospects with board gains – The West Australian

31/03/2023

Endometriosis Awareness Month: What women need to watch out for – THE CAROUSEL

24/03/2023

New blood test for Endometriosis offers improved early screening

24/03/2023

Proteomics reveals new blood test to identify endometriosis – The West Australian

17/03/2023

PromarkerD Application for Australian Medicare Benefits Schedule Listing & Investor Webinar

01/03/2023

Proteomics nears agreement to sell kidney disease test in USA – The West Australian

01/03/2023

US update: PromarkerD licensing negotiations

15/02/2023

Proteomics inks five-year extension to British distribution agreement – The West Australian

15/02/2023

Distribution agreement for PromarkerD in Britain extended

03/01/2023

CPT PLA Reimbursement Code Approved in US for PromarkerD

2022

14/12/2022

UK NICE publishes Medtech Innovation Briefing on PromarkerD

11/11/2022

PromarkerD patent granted in Hong Kong

03/11/2022

Proteomics International to present at the Emerging ASX Gems Conference

20/10/2022

Precision diagnostics facility receives $2m funding boost

17/10/2022

Proteomics receives R&D tax incentive – AuManufacturing

17/10/2022

Proteomics receives $1.7 million in R&D tax incentive

29/09/2022

Cancer test boosts market hopes for Proteomics – The West Australian

27/09/2022

New Oesophageal Cancer Diagnostic shows strong performance

29/08/2022

Proteomics International develops non-invasive blood-based diagnostic for endometriosis – Clarivate BioWorld™

29/08/2022

Proteomics International Laboratories set to expand its commercial footprint in the US [VIDEO] – Proactive Investors

29/08/2022

Proteomics, UWA join forces on new diagnostic test – The West Australian

29/08/2022

OxiDx launched to maximise oxidative stress technology

15/08/2022

Proteomics International raises $8m in highly successful Placement

09/08/2022

Proteomics International signs binding letter of intent with Sonic Healthcare USA to take PromarkerD into the US market

02/08/2022

American doctors give tick to Proteomics kidney test – The West Australian

02/08/2022

Clinical Utility Study demonstrates PromarkerD test benefits

01/08/2022

Potential breakthrough blood test able to detect people with endometriosis

01/08/2022

Boost for Proteomics in fight against painful disorder – The West Australian

25/07/2022

European PromarkerD patents expanded beyond diabetes

30/06/2022

Promarker™ pipeline – Endometriosis update Diagnostic readout positive: Study expanded

28/06/2022

QIMR Berghofer Licenses Esophageal Cancer Blood Biomarkers to Proteomics International – Precision Oncology News

21/06/2022

Proteomics International (ASX:PIQ) secures licence for oesophageal cancer biomarkers – The Market Herald

21/06/2022

Proteomics International secures exclusive licence to oesophageal cancer biomarkers

16/06/2022

Pilot test kit takes Proteomics step closer to sales – The West Australian

16/06/2022

Proteomics International Laboratories (ASX:PIQ) completes PromarkerD manufacturing tech transfer – The Market Herald

16/06/2022

PromarkerD manufacturing tech-transfer completed – Successful production of components for over 50,000 tests

06/06/2022

Study boosts diagnostic potential for Proteomics – The West Australian

06/06/2022

Study shows PromarkerD ability to also predict late-stage kidney decline in type-2 diabetes patients

02/06/2022

PromarkerD registration submitted to the TGA

12/05/2022

Proteomics International awarded funding to support diabetic kidney disease test development – The Market Herald

12/05/2022

Proteomics International awarded $400,000 to support manufacturing capability in Australia

12/04/2022

New Clinical Advisory Board to support PromarkerD global rollout – Yahoo! Finance

12/04/2022

New Clinical Advisory Board for PromarkerD global rollout

24/03/2022

Indian IP win gives Proteomics massive global cover – The West Australian

24/03/2022

PromarkerD patent granted in India

22/02/2022

Proteomics eyes Medicare for rebate inclusion – The West Australian

22/02/2022

PromarkerD completes ‘pre-assessment’ for Medicare rebate